Search hospitals
>
New York
>
Stony Brook
Stony Brook University Medical Center
Claim this profile
Stony Brook, New York 11794
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Heart Failure
Conducts research for Ovarian Cancer
565 reported clinical trials
54 medical researchers
Summary
Stony Brook University Medical Center is a medical facility located in Stony Brook, New York. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Heart Failure, Ovarian Cancer and other specialties. Stony Brook University Medical Center is involved with conducting 565 clinical trials across 980 conditions. There are 54 research doctors associated with this hospital, such as Laura E. Hogan, David Fiorella, MD, Minsig Choi, and Amna Sher.
Area of expertise
Cancer
Stony Brook University Medical Center has run 59 trials for Cancer. Some of their research focus areas include:
Breast Cancer
Stony Brook University Medical Center has run 51 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Laura E. Hogan
Stony Brook University Medical Center
8 years of reported clinical research
David Fiorella, MD
Stony Brook University
1 year of reported clinical research
Minsig Choi
Stony Brook Cancer Center
6 years of reported clinical research
Amna Sher
Stony Brook University Medical Center
4 years of reported clinical research
Clinical Trials running at Stony Brook University Medical Center
Breast Cancer
Lung Cancer
Breast cancer
Prostate Cancer
Multiple Myeloma
Cancer
Testicular cancer
Pancreatic Cancer
Leukemia
Ovarian Carcinoma
PF-07220060 + Letrozole
for Breast Cancer
The purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, ribociclib or abemaciclib with letrozole) in people with breast cancer: * HR-positive (breast cancer cells that need estrogen or progesterone to grow) * HER2-negative (cells that have a small amount or none of a protein called HER2 on their surface); * locally advanced (that has spread from where it started to nearby tissue or lymph nodes) or metastatic disease (the spread of cancer to other places in the body) * who have not received any prior systemic anti-cancer treatment for advanced/metastatic disease. Approximately half of the participants will receive PF-07220060 plus letrozole while the other half of participants will receive the investigator's choice of treatment plus letrozole. The study team will monitor how each participant is doing with the study treatment during regular visits at the study clinic.
Recruiting
2 awards
Phase 3
4 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting
2 awards
Phase 3
15 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting
2 awards
Phase 3
40 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Stony Brook University Medical Center?
Stony Brook University Medical Center is a medical facility located in Stony Brook, New York. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Heart Failure, Ovarian Cancer and other specialties. Stony Brook University Medical Center is involved with conducting 565 clinical trials across 980 conditions. There are 54 research doctors associated with this hospital, such as Laura E. Hogan, David Fiorella, MD, Minsig Choi, and Amna Sher.
Where is Stony Brook University Medical Center located?
**Stony Brook University Medical Center** - **Address:** 101 Nicolls Road, Stony Brook, NY 11794 - **Directions:** Take the Long Island Expressway (I-495) eastbound to Exit 62. Follow Nicolls Road (Route 97) north for approximately 9 miles. The main entrance to the University will be on your left.
Who should I call to ask about financial aid or insurance network?
**Stony Brook University Medical Center Financial and Insurance Assistance:** - **Student Financial Services:** For financial assistance, contact (631) 632-2455. - **FSA Student Insurance Office:** For insurance inquiries, call (631) 632-6054 or email studenthealthinsurance@stonybrook.edu. - **Hospital Bills and Insurance Questions:** Call (631) 444-4151, available Monday - Friday, 8 am - 6 pm.
What insurance does Stony Brook University Medical Center accept?
Stony Brook University Medical Center accepts a variety of insurance plans, including UnitedHealthcare's Domestic and International Student Health Insurance Plans. These plans offer comprehensive coverage for services such as mental health, primary care, specialists, emergency and hospital services, and preventative care, with a $50 deductible per injury or sickness. The Medical Center also participates in numerous health plan networks; it's crucial to verify if your specific plan considers Stony Brook Medicine hospitals or physicians in-network to avoid "Out of Network" charges.
What awards or recognition has Stony Brook University Medical Center received?
Stony Brook University Hospital is recognized as one of the 90 "Great Hospitals in America" by Becker's Hospital Review, highlighting its commitment to clinical excellence, patient safety, innovation, research, and education. It has earned national recognition from U.S. News & World Report in Neurology and Neurosurgery, Orthopaedics, Urology, Diabetes and Endocrinology, Gastroenterology and GI Surgery, Geriatrics, Nephrology, and Pulmonology and Lung Surgery. Additionally, it is the first organization on Long Island to receive the Health Care Equity Certification from The Joint Commission.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.